Agency Forms Undergoing Paperwork Reduction Act Review, 12753-12754 [2010-5843]

Download as PDF wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1 Federal Register / Vol. 75, No. 51 / Wednesday, March 17, 2010 / Notices healthit.hhs.gov. Please check the ONC Web site for additional information as it becomes available. Contact Person: Judy Sparrow, Office of the National Coordinator, HHS, 330 C Street, SW., Washington, DC 20201, 202–205–4528, Fax: 202–690–6079, email: judy.sparrow@hhs.gov Please call the contact person for up-to-date information on these meetings. A notice in the Federal Register about last minute modifications that affect a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Agenda: The workgroups will be discussing issues related to their specific subject matter, e.g., meaningful use, the NHIN, privacy and security policy, adoption/certification, or strategic planning. If background materials are associated with the workgroup meetings, they will be posted on ONC’s Web site prior to the meeting at https://healthit.hhs.gov. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the workgroups. Written submissions may be made to the contact person on or before two days prior to the workgroups’ meeting date. Oral comments from the public will be scheduled at the conclusion of each workgroup meeting. Time allotted for each presentation will be limited to three minutes. If the number of speakers requesting to comment is greater than can be reasonably accommodated during the scheduled open public session, ONC will take written comments after the meeting until close of business on that day. If you require special accommodations due to a disability, please contact Judy Sparrow at least seven (7) days in advance of the meeting. ONC is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://healthit.hhs.gov for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S.C., App. 2). Dated: March 11, 2010. Judith Sparrow, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. 2010–5783 Filed 3–16–10; 8:45 am] BILLING CODE 4150–45–P VerDate Nov<24>2008 15:08 Mar 16, 2010 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology; HIT Standards Committee’s Workgroup Meetings; Notice of Meetings AGENCY: Office of the National Coordinator for Health Information Technology, HHS. ACTION: Notice of meetings. This notice announces forthcoming subcommittee meetings of a federal advisory committee of the Office of the National Coordinator for Health Information Technology (ONC). The meetings will be open to the public via dial-in access only. Name of Committees: HIT Standards Committee’s Workgroups: Clinical Operations Vocabulary, Clinical Quality, Implementation, and Privacy & Security workgroups. General Function of the Committee: To provide recommendations to the National Coordinator on standards, implementation specifications, and certification criteria for the electronic exchange and use of health information for purposes of adoption, consistent with the implementation of the Federal Health IT Strategic Plan, and in accordance with policies developed by the HIT Policy Committee. Date and Time: The HIT Standards Committee Workgroups will hold the following public meetings during April 2010: April 1st Privacy & Security Workgroup, webcast only, 10 a.m. to 12 p.m./ET; April 23rd Clinical Quality Workgroup, 10 a.m. to 12 p.m./ET; April 23rd Privacy & Security Workgroup, 2 p.m. to 4 p.m./ET; and April 30th Implementation Workgroup, 3 p.m. to 4 p.m./ET. Location: All workgroup meetings will be available via webcast; visit https://healthit.hhs.gov for instructions on how to listen via telephone or Web. Please check the ONC Web site for additional information as it becomes available. Contact Person: Judy Sparrow, Office of the National Coordinator, HHS, 330 C Street, SW., Washington, DC 20201, 202–205–4528, Fax: 202–690–6079, email: judy.sparrow@hhs.gov. Please call the contact person for up-to-date information on these meetings. A notice in the Federal Register about last minute modifications that affect a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Agenda: The workgroups will be discussing issues related to their PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 12753 specific subject matter, e.g., clinical operations vocabulary standards, clinical quality measure, implementation opportunities and challenges, and privacy and security standards activities. If background materials are associated with the workgroup meetings, they will be posted on ONC’s Web site prior to the meeting at https://healthit.hhs.gov. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the workgroups. Written submissions may be made to the contact person on or before two days prior to the workgroups’ meeting date. Oral comments from the public will be scheduled at the conclusion of each workgroup meeting. Time allotted for each presentation will be limited to three minutes. If the number of speakers requesting to comment is greater than can be reasonably accommodated during the scheduled open public session, ONC will take written comments after the meeting until close of business on that day. If you require special accommodations due to a disability, please contact Judy Sparrow at least seven (7) days in advance of the meeting. ONC is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://healthit.hhs.gov for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S.C., App. 2). Dated: March 11, 2010. Judith Sparrow, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. 2010–5784 Filed 3–16–10; 8:45 am] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30-Day–10–09CD] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance E:\FR\FM\17MRN1.SGM 17MRN1 12754 Federal Register / Vol. 75, No. 51 / Wednesday, March 17, 2010 / Notices Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Laboratory Medicine Best Practices Project (LMBP)—New—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) (proposed), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC is seeking approval from the Office of Management and Budget (OMB) to collect information from healthcare organizations in order to conduct a systemic review of laboratory practice effectiveness. The purpose of information collection is to include completed unpublished quality improvement studies/assessments carried out by healthcare organizations (laboratories, hospitals, clinics) in systematic reviews of practice effectiveness. CDC has been sponsoring the Laboratory Medicine Best Practices (LMBP) initiative to develop new systematic evidence reviews methods for making evidence-based recommendations in laboratory medicine. This initiative supports the CDC’s mission of improving laboratory practices. The focus of the Initiative is on preand post-analytic laboratory medicine practices that are effective at improving health care quality. While evidencebased approaches for decisionmaking have become standard in healthcare, this has been limited in laboratory medicine. No single-evidence-based model for recommending practices in laboratory medicine exists, although the number of laboratories operating in the United States and the volume of laboratory tests available certainly warrant such a model. The Laboratory Medicine Best Practices Initiative began in October 2006, when Division of Laboratory Systems (DLS) convened the Laboratory Medicine Best Practices Workgroup (Workgroup), a multidisciplinary panel of experts in several fields including laboratory medicine, clinical medicine, health services research, and health care performance measurement. The Workgroup has been supported by staff at CDC and the Battelle Memorial Institute under contract to CDC. To date, the Laboratory Medicine Best Practices (LMBP) project work has been completed over three phases. During Phase 1 (October 2006–September 2007) of the project, CDC staff developed systematic review methods for conducting paper reviews related to the effectiveness of laboratory medicine practices. Results of a review of practices that reduce patient specimen identification indicated that an insufficient quality and number of published studies were available for completing systematic evidence reviews of laboratory medicine practice effectiveness for multiple practices. These results were considered likely to be generalizable to most potential review topics of interest. A finding from Phase 1 work was that laboratories would be unlikely to publish quality improvement projects or studies demonstrating practice effectiveness in the peer reviewed literature, but that they routinely conducted quality improvement projects and had relevant data for completion of evidence reviews. Phase 2 (September 2007–November 2008) and Phase 3 (December 2008– September 2009), involved further development of methods to obtain and critically appraise published and unpublished data. A pilot test of a standardized data collection form with less than nine potential laboratory respondents supported the Phase 1 finding that data from completed laboratory medicine quality improvement projects could supplement published evidence in systematic reviews. The objective for successive LMBP evidence reviews of practice effectiveness is to supplement the published evidence with unpublished evidence to fill in gaps in the literature. Healthcare organizations and facilities (laboratories, hospitals, clinics) will have the opportunity to voluntarily enroll in an LMBP network and submit readily available unpublished studies; quality improvement projects, evaluations, assessments, and other analyses relying on unlinked, anonymous data using the LMBP Submission Form. LMBP Network participants will also be able to submit unpublished studies/data for evidence reviews on an annual basis using this form. There will be no charge to respondents for their participation, other than their time. The total estimated annualized burden hours for this information collection request are 138 hours. ESTIMATED ANNUALIZED BURDEN HOURS Respondents Number of respondents Number of responses per respondent Average burden per response (in hours) Healthcare Organizations ............................................................................................................ 150 1 55/60 Date: March 11, 2010. Maryam I. Daneschvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1 [FR Doc. 2010–5843 Filed 3–16–10; 8:45 am] Centers for Disease Control and Prevention BILLING CODE 4163–18–P [60-Day–10–10CB] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on VerDate Nov<24>2008 15:08 Mar 16, 2010 Jkt 220001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information E:\FR\FM\17MRN1.SGM 17MRN1

Agencies

[Federal Register Volume 75, Number 51 (Wednesday, March 17, 2010)]
[Notices]
[Pages 12753-12754]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5843]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day-10-09CD]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance

[[Page 12754]]

Officer at (404) 639-5960 or send an e-mail to omb@cdc.gov. Send 
written comments to CDC Desk Officer, Office of Management and Budget, 
Washington, DC or by fax to (202) 395-5806. Written comments should be 
received within 30 days of this notice.

Proposed Project

    Laboratory Medicine Best Practices Project (LMBP)--New--National 
Center for Emerging and Zoonotic Infectious Diseases (NCEZID) 
(proposed), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is seeking approval from the Office of Management and Budget 
(OMB) to collect information from healthcare organizations in order to 
conduct a systemic review of laboratory practice effectiveness. The 
purpose of information collection is to include completed unpublished 
quality improvement studies/assessments carried out by healthcare 
organizations (laboratories, hospitals, clinics) in systematic reviews 
of practice effectiveness. CDC has been sponsoring the Laboratory 
Medicine Best Practices (LMBP) initiative to develop new systematic 
evidence reviews methods for making evidence-based recommendations in 
laboratory medicine. This initiative supports the CDC's mission of 
improving laboratory practices.
    The focus of the Initiative is on pre- and post-analytic laboratory 
medicine practices that are effective at improving health care quality. 
While evidence-based approaches for decisionmaking have become standard 
in healthcare, this has been limited in laboratory medicine. No single-
evidence-based model for recommending practices in laboratory medicine 
exists, although the number of laboratories operating in the United 
States and the volume of laboratory tests available certainly warrant 
such a model.
    The Laboratory Medicine Best Practices Initiative began in October 
2006, when Division of Laboratory Systems (DLS) convened the Laboratory 
Medicine Best Practices Workgroup (Workgroup), a multidisciplinary 
panel of experts in several fields including laboratory medicine, 
clinical medicine, health services research, and health care 
performance measurement. The Workgroup has been supported by staff at 
CDC and the Battelle Memorial Institute under contract to CDC.
    To date, the Laboratory Medicine Best Practices (LMBP) project work 
has been completed over three phases. During Phase 1 (October 2006-
September 2007) of the project, CDC staff developed systematic review 
methods for conducting paper reviews related to the effectiveness of 
laboratory medicine practices. Results of a review of practices that 
reduce patient specimen identification indicated that an insufficient 
quality and number of published studies were available for completing 
systematic evidence reviews of laboratory medicine practice 
effectiveness for multiple practices. These results were considered 
likely to be generalizable to most potential review topics of interest. 
A finding from Phase 1 work was that laboratories would be unlikely to 
publish quality improvement projects or studies demonstrating practice 
effectiveness in the peer reviewed literature, but that they routinely 
conducted quality improvement projects and had relevant data for 
completion of evidence reviews. Phase 2 (September 2007-November 2008) 
and Phase 3 (December 2008-September 2009), involved further 
development of methods to obtain and critically appraise published and 
unpublished data. A pilot test of a standardized data collection form 
with less than nine potential laboratory respondents supported the 
Phase 1 finding that data from completed laboratory medicine quality 
improvement projects could supplement published evidence in systematic 
reviews. The objective for successive LMBP evidence reviews of practice 
effectiveness is to supplement the published evidence with unpublished 
evidence to fill in gaps in the literature.
    Healthcare organizations and facilities (laboratories, hospitals, 
clinics) will have the opportunity to voluntarily enroll in an LMBP 
network and submit readily available unpublished studies; quality 
improvement projects, evaluations, assessments, and other analyses 
relying on unlinked, anonymous data using the LMBP Submission Form. 
LMBP Network participants will also be able to submit unpublished 
studies/data for evidence reviews on an annual basis using this form. 
There will be no charge to respondents for their participation, other 
than their time. The total estimated annualized burden hours for this 
information collection request are 138 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of     Average  burden
                         Respondents                              Number of      responses per    per  response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
Healthcare Organizations.....................................             150                1            55/60
----------------------------------------------------------------------------------------------------------------


    Date: March 11, 2010.
Maryam I. Daneschvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-5843 Filed 3-16-10; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.